WAYNE, Pa., Oct. 23 /PRNewswire-FirstCall/ -- Escalon Medical Corp. (Nasdaq: ESMC) today announced its Sonomed, Inc. subsidiary's introduction of the new PacScan(TM) Plus, an A-Scan with optional pachymeter.
"The PacScan(TM) Plus is the latest generation of our combination instruments, and incorporates several advancements, including provision of three post-refractive IOL formulas," Barry Durante, President, commented. "The data storage and transfer capabilities, built-in printer, and probe storage compartment make the PacScan(TM) Plus a truly portable full-function system."
Sonomed will be demonstrating the PacScan(TM) Plus at the upcoming AAO meeting in San Francisco, CA October 24-27, 2009.
The PacScan(TM) Plus features a large high-contrast color LCD, five programmable user profiles, and nine IOL formulas, including three post-refractive. Immersion and direct contact scanning is provided with cataract, dense cataract, aphakic, pseudophakic and 4-gate manual modes. The PacScan(TM) Plus has a USB port for EMR archiving and a SD disk port for patient data storage, as well as a built-in thermal printer, built-in probe holders, probe storage compartment, and individual probe connectors.
Founded in 1987, the Company (www.escalonmed.com) develops markets and distributes ophthalmic diagnostic, surgical and pharmaceutical products as well as vascular access devices. Drew Scientific, which operates as a separate business unit, provides instrumentation and consumables for the diagnosis and monitoring of medical disorders in the areas of diabetes, cardiovascular diseases and hematology, as well as veterinary hematology and blood chemistry. The Company seeks to utilize strategic partnerships to help finance its development programs and is also seeking acquisitions to further diversify its product line to achieve critical mass in sales and take better advantage of the Company 's distribution capabilities, although such partnerships or acquisitions may not occur. The Company has headquarters in Wayne, Pennsylvania and operations in Long Island, New York, New Berlin, Wisconsin, Lawrence, Massachusetts, Dallas, Texas, Waterbury, Connecticut, Miami, Florida, Barrow-in-Furness, U.K. and Le Rheu, France.
Note: This press release contains statements that are considered forward-looking under the Private Securities Litigation Reform Act of 1995, including statements about the Company's future prospects. These statements are based on the Company's current expectations and are subject to a number of uncertainties and risks, and actual results may differ materially. The uncertainties and risks include whether the Company is able to:
Other factors include uncertainties and risks related to:
Further information about these and other relevant risks and uncertainties may be found in the Company's report on Form 10- K for year ended June 30, 2009, and its other filings with the Securities and Exchange Commission, all of which are available from the Securities and Exchange Commission as well as other sources.
SOURCE Escalon Medical Corp.
|SOURCE Escalon Medical Corp.|
Copyright©2009 PR Newswire.
All rights reserved